My watch list
my.bionity.com  
Login  
MARKET STUDIES

Gastroenteritis - Pipeline Review, Q2 2011

Introduction Global Markets Direct’s, 'Gastroenteritis - Pipeline Review, Q2 2011', provides an overview of the Gastroenteritis therapeutic pipel ...

Anaplastic Thyroid Cancer – Pipeline Review, H2 2012

Introduction Global Markets Direct’s, 'Anaplastic Thyroid Cancer - Pipeline Review, H2 2012', provides an overview of the Anaplastic Thyroid Can ...

Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic SWOT Analysis ...

Taiko Pharmaceutical Co.,Ltd. (Taiko) is a pharmaceutical company that is engaged in the manufacture, sale and export of gastrointestinal drugs un ...

Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic ...

Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review Summary Valeant Pharmaceuticals International, ...

Replek AD Skopje (REPL) - Financial and Strategic SWOT Analysis Review

Replek AD Skopje (Replek AD) is a healthcare company, engaged in the manufacture, marketing and distribution of pharmaceuticals, medical devices a ...

Current market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains negative. That aside, BMI emphasises that the number-one concern for drugmakers in 201 ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psoriasis. It includes an overview of the tri ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also involved in providing various health care services. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AI ... more

China Chinese Prepared Medicines Mfg. Industry Profile

Through a comparative analysis on the development of Chinese prepared medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the Chinese prepared medicines mfg. industry in China, a list of ma ... more

Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018

Introduction ”Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile ENT Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment ... more

News on market trends
  • Recipharm completes strategic acquisition in India

    Recipharm AB announces that it has now concluded the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. The expands position in emerging markets significantly, taking sales in these markets to more than SEK 800 million, dominated by sales directly to the fast-growing pha more

  • Merck opens production facility exclusively for meglumine in Spain

    Merck announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.The facility, validated by the FDA, is the only location in Europe that manufactures meglum more

  • Grünenthal introduces Latin America’s most modern Women’s Health Products plant

    Grünenthal announced the introduction of its new women’s health products plant today. Grünenthal invested USD 14.5 million to build the 1,150 m 2 hormone plant, which is the company’s center of excellence for hormone production and the most modern in Latin America. The new facility will initially de more

  • WACKER expands its production of cysteine

    WACKER BIOSOLUTIONS, the life sciences and biotechnology division of the WACKER Group, is acquiring a large-scale fermentation plant from Antibióticos de León SLU (ADL) in Spain. The two companies announced the signing of the contract of sale. At the León plant, WACKER will produce cysteine by ferme more

  • Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant

    Takeda Pharmaceutical Company Limited announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. This represents a major step by Takeda toward meeting important unmet needs in dengue prevention. According to the W more

  • Novozymes expands in India

    To accommodate business growth and a consequent increase in production and supply chain needs, Novozymes has obtained land on a long-term lease in the Patalganga industrial area near Mumbai on India’s west coast. With an initial investment of approximately DKK 300 million the company plans to establ more

  • Eppendorf acquires Calibration Technology

    Hamburg-based Eppendorf AG acquired Calibration Technology Ltd, headquartered in the National Technology Park Limerick, Ireland, on November 1. The company will continue to be managed as a wholly owned subsidiary of Eppendorf AG by its current Managing Director, Brian Kelly. The acquisition of Calib more

  • Agendia expands its business activities in Germany

    Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the expansion of its business activities in Germany. The Company has launched the “BRIDGE” patient initiative to enable more physicians and their patients to access the additional benefits of itsMamma more

  • SCIENION opens French subsidiary Cellenion with focus on controlled cell dispensing technologies

    SCIENION AG, a provider for ultra-low volume liquid handling applications, announced that its new subsidiary Cellenion S.A.S. started operations in Lyon, France back in May 2016. Cellenion focuses on controlled cell dispensing technologies in the fields of bioprinting and single-cell dispensing. R&D more

  • Bluebee opens a new corporate office in Boston

    Bluebee, a pioneer in cloud-based high performance genomics solutions, announced that it is expanding with a new corporate office in the Boston, MA. Over the year, Bluebee has established close relationships with major research and clinical labs in the United States, and expanding its operations is more

New market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenari ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also invol ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE